Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus

Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus

This is the first study performed in population from Bosnia & Herzegovina (BH), in which we analysed a significance of genetic variations in drug-metabolising enzyme, cytochrome P450 (CYP), in pathogenesis of Type 2 diabetes. We have determined allele frequencies for CYP2C9*2, CYP2C19*2, and CY...

Full description

Bibliographic Details
Main Authors: Sabina Semiz, Tanja Dujic, Barbara Ostanek, Besim Prnjavorac, Tamer Bego, Maja Malenica, Janja Marc, Adlija Causevic
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2010-11-01
Series:Biomolecules & Biomedicine
Subjects:
drug-metabolising enzymes
CYP2C9
CYP2C19
CYP2D6
diabetes
pharmacogenetics
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/2662

Similar Items

Similar Items